By preventing the phosphorylation and subsequent degradation of its inhibitor, IκBα, CAPE directly abrogates the nuclear translocation of active NF-κB dimers in cells such as tumor-associated macrophages (TAMs) and cancer cells [6,10,108,114,115]. Here, NFKB1 is linked to cancer.